Literature DB >> 18299732

Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999.

M Bashash1, A Shah, G Hislop, A Brooks-Wilson, N Le, C Bajdik.   

Abstract

BACKGROUND: Geographical variation and temporal trends in the incidence of esophageal and gastric cancers vary according to both tumour morphology and organ subsite. Both diseases are among the deadliest forms of cancer. The incidence and survival rates for gastric and esophageal carcinoma in British Columbia (BC) between 1990 and 1999 are described.
METHODS: Incidence data for the period 1990 to 1999 were obtained from the BC Cancer Registry. Age-adjusted incidence and survival rates were computed by anatomical subsite, histological type and sex. All rates were standardized to the 1996 Canadian population. The estimated annual percentage change (EAPC) was used to measure incidence changes over time. Kaplan-Meier curves were used to show survival rates, and log-rank tests were used to test for differences in the curves among various groups.
RESULTS: Between 1990 and 1999, 1741 esophageal cancer cases and 3431 gastric cancer cases were registered in BC. There was an increase in the incidence of adenocarcinoma of the esophagus over time (EAPC=9.6%) among men, and of gastric cardia cancer among both women (EAPC=9.2%) and men (EAPC=3.8%). Patients with proximal gastric (cardia) cancer had significantly better survival rates than patients with cancer in the lower one-third of the esophagus. Among gastric cancers, patients with distal tumours had a significantly better survival rate than patients with proximal tumours. DISCUSSION: The incidences of proximal gastric cancer and esophageal adenocarcinoma are increasing, and their survival patterns are different. Examining these cancers together may elucidate new etiological and prognostic factors.

Entities:  

Mesh:

Year:  2008        PMID: 18299732      PMCID: PMC2659133          DOI: 10.1155/2008/645107

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  36 in total

1.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

Review 2.  Epidemiologic trends in esophageal and gastric cancer in the United States.

Authors:  Linda Morris Brown; Susan S Devesa
Journal:  Surg Oncol Clin N Am       Date:  2002-04       Impact factor: 3.495

3.  Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States.

Authors:  Ai Kubo; Douglas A Corley
Journal:  Cancer       Date:  2002-11-15       Impact factor: 6.860

4.  Continuing rising trend in oesophageal adenocarcinoma.

Authors:  Jean Powell; Chris C McConkey; E Walford Gillison; Robert T Spychal
Journal:  Int J Cancer       Date:  2002-12-01       Impact factor: 7.396

5.  Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world.

Authors:  J R Siewert; H J Stein; M Feith; B L Bruecher; H Bartels; U Fink
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

6.  Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach.

Authors:  Hiroaki Saito; Youji Fukumoto; Tomohiro Osaki; Kenji Fukuda; Shigeru Tatebe; Shunichi Tsujitani; Masahide Ikeguchi
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

7.  Screening for esophageal adenocarcinoma: an evidence-based approach.

Authors:  Lauren B Gerson; George Triadafilopoulos
Journal:  Am J Med       Date:  2002-10-15       Impact factor: 4.965

8.  Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA.

Authors:  H B El-Serag; A C Mason; N Petersen; C R Key
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

9.  Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.

Authors:  Sharlene Gill; Amil Shah; Nhu Le; E Francis Cook; Eric M Yoshida
Journal:  J Clin Oncol       Date:  2003-06-01       Impact factor: 44.544

10.  Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).

Authors:  Carlos A González; Guillem Pera; Antonio Agudo; Domenico Palli; Vittorio Krogh; Paolo Vineis; Rosario Tumino; Salvatore Panico; Göran Berglund; Henrik Simán; Olof Nyrén; Asa Agren; Carmen Martinez; Miren Dorronsoro; Aurelio Barricarte; María J Tormo; Jose R Quiros; Naomi Allen; Sheila Bingham; Nicholas Day; Antony Miller; Gabriele Nagel; Heiner Boeing; Kim Overvad; Anne Tjonneland; H Bas Bueno-De-Mesquita; Hendriek C Boshuizen; Petra Peeters; Mattijs Numans; François Clavel-Chapelon; Ishaki Helen; Emmanuel Agapitos; Eiliv Lund; Michael Fahey; Rodolfo Saracci; Rudolf Kaaks; Elio Riboli
Journal:  Int J Cancer       Date:  2003-11-20       Impact factor: 7.396

View more
  14 in total

1.  Descriptive epidemiology of gastric adenocarcinoma in the state of Texas by ethnicity: Hispanic versus White non-Hispanic.

Authors:  Babak Rajabi; Javier C Corral; Nawar Hakim; Zuber D Mulla
Journal:  Gastric Cancer       Date:  2012-01-18       Impact factor: 7.370

2.  Decreasing morbidity and mortality in 100 consecutive minimally invasive esophagectomies.

Authors:  Kfir Ben-David; George A Sarosi; Juan C Cendan; Drew Howard; Georgios Rossidis; Steven N Hochwald
Journal:  Surg Endosc       Date:  2011-07-27       Impact factor: 4.584

3.  A population-based analysis of esophageal and gastric cardia adenocarcinomas in Ontario, Canada: incidence, risk factors, and regional variation.

Authors:  Jill Tinmouth; Josh Green; Yoo-Joung Ko; Ying Liu; Lawrence Paszat; Rinku Sutradhar; Linda Rabeneck; David Urbach
Journal:  J Gastrointest Surg       Date:  2011-03-16       Impact factor: 3.452

4.  Esophageal cancer in Canada: trends according to morphology and anatomical location.

Authors:  Michael C Otterstatter; James D Brierley; Prithwish De; Larry F Ellison; Maureen Macintyre; Loraine D Marrett; Robert Semenciw; Hannah K Weir
Journal:  Can J Gastroenterol       Date:  2012-10       Impact factor: 3.522

5.  Comparison of two diverse populations, British Columbia, Canada, and Ardabil, Iran, indicates several variables associated with gastric and esophageal cancer survival.

Authors:  Morteza Bashash; Parvin Yavari; T Greg Hislop; Amil Shah; Alireza Sadjadi; Masoud Babaei; Nhu Le; Angela Brooks-Wilson; Reza Malekzadeh; Chris Bajdik
Journal:  J Gastrointest Cancer       Date:  2011-03

6.  The prognostic effect of ethnicity for gastric and esophageal cancer: the population-based experience in British Columbia, Canada.

Authors:  Morteza Bashash; T Greg Hislop; Amil M Shah; Nhu Le; Angela Brooks-Wilson; Chris D Bajdik
Journal:  BMC Cancer       Date:  2011-05-09       Impact factor: 4.430

7.  Demographic and histological predictors of survival in patients with gastric and esophageal carcinoma.

Authors:  Yousef Veisani; Ali Delpisheh; Kourosh Sayehmiri; Ezzatollah Rahimi
Journal:  Iran Red Crescent Med J       Date:  2013-07-05       Impact factor: 0.611

8.  Incidence, Survival and Prognostic Factors of Oesophagogastric Cancer.

Authors:  Nurul Syuhada Ishak; Hanif Abdul Rahman; Shirley H F Lee; Shir Kiong Lu; Lin Naing
Journal:  J Gastrointest Cancer       Date:  2021-01-04

9.  Genetic polymorphisms at TIMP3 are associated with survival of adenocarcinoma of the gastroesophageal junction.

Authors:  Morteza Bashash; Amil Shah; Greg Hislop; Martin Treml; Karla Bretherick; Rozmin Janoo-Gilani; Stephen Leach; Nhu Le; Chris Bajdik; Angela Brooks-Wilson
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Esophageal carcinoma: long-term survival in consecutive series of patients through a retrospective cohort study.

Authors:  Ali Delpisheh; Yousef Veisani; Kourosh Sayehmiri; Ezzatollah Rahimi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.